S. Yang

Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance

N. Nassif, D. Joshua, Ross D. Brown, 2013, Blood Cancer Journal.

Long-term survival in multiple myeloma is associated with a distinct immunological profile , which includes proliferative cytotoxic T-cell clones and a favourable Treg / Th 17 balance

N. Nassif, P. Fromm, D. Hart, 2013 .

Characterisation and relevance of CD138‐negative plasma cells in plasma cell myeloma

D. Joshua, R. Brown, N. Woodland, 2010, International journal of laboratory hematology.

Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade

N. Nassif, C. Weatherburn, D. Joshua, 2016, Leukemia.

The failure of immune checkpoint blockade in multiple myeloma with PD-1 inhibitors in a phase 1 study

D. Joshua, R. Brown, J. Gibson, 2015, Leukemia.

Phospho-flow detection of constitutive and cytokine-induced pSTAT3/5, pAKT and pERK expression highlights novel prognostic biomarkers for patients with multiple myeloma

C. Weatherburn, D. Joshua, D. Hart, 2014, Leukemia.